Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities
The relationship between epilepsy and psychiatric comorbidities has been recognized for centuries, but its pathophysiological mechanisms are still misunderstood. It is biologically plausible that genetic or epigenetic variations in genes that codify important neurotransmitters involved in epilepsy a...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0047d4ff22034b38b10c5318e4faff44 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0047d4ff22034b38b10c5318e4faff44 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0047d4ff22034b38b10c5318e4faff442021-12-01T13:35:19ZMethylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities1662-514510.3389/fnint.2021.764742https://doaj.org/article/0047d4ff22034b38b10c5318e4faff442021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnint.2021.764742/fullhttps://doaj.org/toc/1662-5145The relationship between epilepsy and psychiatric comorbidities has been recognized for centuries, but its pathophysiological mechanisms are still misunderstood. It is biologically plausible that genetic or epigenetic variations in genes that codify important neurotransmitters involved in epilepsy as well as in psychiatric disorders may influence the development of the latter in patients with epilepsy. However, this possibility remains poorly investigated. The aim of this study was to evaluate the methylation profile of the BDNF and SLC6A4, two genes importantly involved in neuroplasticity, in patients with temporal lobe epilepsy (TLE) regarding the development or not of psychiatric comorbidities. One hundred and thirty-nine patients with TLE, 90 females and 45 males, were included in the study. The mean age of patients was 44.0 (+12.0) years, and mean duration of epilepsy was 25.7 (+13.3) years. The Structured Clinical Interview for DSM-IV shows that 83 patients (59.7%) had neuropsychiatric disorders and 56 (40.3%) showed no psychiatric comorbidity. Mood disorders were the most common psychiatric disorder observed, being present in 64 (46.0%) of all 139 patients. Thirty-three (23.7%) patients showed anxiety disorders, 10 (7.2%) patients showed history of psychosis and 8 (5.8%) patients showed history of alcohol//drug abuse. Considering all 139 patients, 18 (12.9%) demonstrated methylation of the promoter region of both BDNF and SLC6A4 genes. A significant decreased methylation profile was observed only in TLE patients with mood disorders when compared with TLE patients without a history of mood disorders (O.R. = 3.45; 95% C.I. = 1.08–11.11; p = 0.04). A sub-analysis showed that TLE patients with major depressive disorder mostly account for this result (O.R. = 7.20; 95% C.I. = 1.01–56.16; p = 0.042). A logistic regression analysis showed that the independent factors associated with a history of depression in our TLE patients was female sex (O.R. = 2.30; 95% C.I. = 1.02–5.18; p = 0.044), not controlled seizures (O.R. = 2.51; 95% C.I. = 1.16–5.41; p = 0.019) and decreased methylation in BDNF and SLC6A4 genes (O.R. = 5.32; 95% C.I. = 1.14–25.00; p = 0.033). Our results suggest that BDNF or SLC6A4 genes profile methylation is independently associated with depressive disorders in patients with epilepsy. Further studies are necessary to clarify these matters.Isabel Cristina BandeiraIsabel Cristina BandeiraLucas GiombelliIsabel Cristina WerlangIsabel Cristina WerlangAna Lucia AbujamraThais Leite SecchiRosane BrondaniRosane BrondaniJosé Augusto BragattiJorge Wladimir Junqueira BizziSandra Leistner-SegalSandra Leistner-SegalMarino Muxfeldt BianchinMarino Muxfeldt BianchinMarino Muxfeldt BianchinMarino Muxfeldt BianchinFrontiers Media S.A.articlemethylationpsychiatric comorbiditiesdepressionBDNFserotoninneurotrophinsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENFrontiers in Integrative Neuroscience, Vol 15 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
methylation psychiatric comorbidities depression BDNF serotonin neurotrophins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
methylation psychiatric comorbidities depression BDNF serotonin neurotrophins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Isabel Cristina Bandeira Isabel Cristina Bandeira Lucas Giombelli Isabel Cristina Werlang Isabel Cristina Werlang Ana Lucia Abujamra Thais Leite Secchi Rosane Brondani Rosane Brondani José Augusto Bragatti Jorge Wladimir Junqueira Bizzi Sandra Leistner-Segal Sandra Leistner-Segal Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| description |
The relationship between epilepsy and psychiatric comorbidities has been recognized for centuries, but its pathophysiological mechanisms are still misunderstood. It is biologically plausible that genetic or epigenetic variations in genes that codify important neurotransmitters involved in epilepsy as well as in psychiatric disorders may influence the development of the latter in patients with epilepsy. However, this possibility remains poorly investigated. The aim of this study was to evaluate the methylation profile of the BDNF and SLC6A4, two genes importantly involved in neuroplasticity, in patients with temporal lobe epilepsy (TLE) regarding the development or not of psychiatric comorbidities. One hundred and thirty-nine patients with TLE, 90 females and 45 males, were included in the study. The mean age of patients was 44.0 (+12.0) years, and mean duration of epilepsy was 25.7 (+13.3) years. The Structured Clinical Interview for DSM-IV shows that 83 patients (59.7%) had neuropsychiatric disorders and 56 (40.3%) showed no psychiatric comorbidity. Mood disorders were the most common psychiatric disorder observed, being present in 64 (46.0%) of all 139 patients. Thirty-three (23.7%) patients showed anxiety disorders, 10 (7.2%) patients showed history of psychosis and 8 (5.8%) patients showed history of alcohol//drug abuse. Considering all 139 patients, 18 (12.9%) demonstrated methylation of the promoter region of both BDNF and SLC6A4 genes. A significant decreased methylation profile was observed only in TLE patients with mood disorders when compared with TLE patients without a history of mood disorders (O.R. = 3.45; 95% C.I. = 1.08–11.11; p = 0.04). A sub-analysis showed that TLE patients with major depressive disorder mostly account for this result (O.R. = 7.20; 95% C.I. = 1.01–56.16; p = 0.042). A logistic regression analysis showed that the independent factors associated with a history of depression in our TLE patients was female sex (O.R. = 2.30; 95% C.I. = 1.02–5.18; p = 0.044), not controlled seizures (O.R. = 2.51; 95% C.I. = 1.16–5.41; p = 0.019) and decreased methylation in BDNF and SLC6A4 genes (O.R. = 5.32; 95% C.I. = 1.14–25.00; p = 0.033). Our results suggest that BDNF or SLC6A4 genes profile methylation is independently associated with depressive disorders in patients with epilepsy. Further studies are necessary to clarify these matters. |
| format |
article |
| author |
Isabel Cristina Bandeira Isabel Cristina Bandeira Lucas Giombelli Isabel Cristina Werlang Isabel Cristina Werlang Ana Lucia Abujamra Thais Leite Secchi Rosane Brondani Rosane Brondani José Augusto Bragatti Jorge Wladimir Junqueira Bizzi Sandra Leistner-Segal Sandra Leistner-Segal Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin |
| author_facet |
Isabel Cristina Bandeira Isabel Cristina Bandeira Lucas Giombelli Isabel Cristina Werlang Isabel Cristina Werlang Ana Lucia Abujamra Thais Leite Secchi Rosane Brondani Rosane Brondani José Augusto Bragatti Jorge Wladimir Junqueira Bizzi Sandra Leistner-Segal Sandra Leistner-Segal Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin Marino Muxfeldt Bianchin |
| author_sort |
Isabel Cristina Bandeira |
| title |
Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| title_short |
Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| title_full |
Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| title_fullStr |
Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| title_full_unstemmed |
Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities |
| title_sort |
methylation of bdnf and slc6a4 gene promoters in brazilian patients with temporal lobe epilepsy presenting or not psychiatric comorbidities |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/0047d4ff22034b38b10c5318e4faff44 |
| work_keys_str_mv |
AT isabelcristinabandeira methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT isabelcristinabandeira methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT lucasgiombelli methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT isabelcristinawerlang methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT isabelcristinawerlang methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT analuciaabujamra methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT thaisleitesecchi methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT rosanebrondani methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT rosanebrondani methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT joseaugustobragatti methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT jorgewladimirjunqueirabizzi methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT sandraleistnersegal methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT sandraleistnersegal methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT marinomuxfeldtbianchin methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT marinomuxfeldtbianchin methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT marinomuxfeldtbianchin methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities AT marinomuxfeldtbianchin methylationofbdnfandslc6a4genepromotersinbrazilianpatientswithtemporallobeepilepsypresentingornotpsychiatriccomorbidities |
| _version_ |
1718405095759020032 |